The London-listed drugmaker reported an adjusted profit of 37 pence per share on revenue of about 7 billion pounds ($8.. 70 billion).. Analysts were expecting 33.. 2 pence per share on revenue of about 6.. 5 billion pounds, according to company-compiled consensus estimates.. The company's blockbuster shingles vaccine, Shingrix, generated 833 million pounds, ahead of than the GSK-compiled consensus of 829 million pounds.